ROBERTO DIAZ BEVERIDGE, MD

HU LA FE
VALENCIA, Comunidad Valenciana, Spain

Presentation(s):

• Paper 14 - IMMUNOSARC2 (COHORT 7A): A SPANISH SARCOMA GROUP (GEIS) PHASE IB TRIAL OF EPIRUBICIN AND IFOSFAMIDE PLUS NIVOLUMAB IN FIRST LINE OF ADVANCED UNDIFFERENTIATED PLEOMORPHIC SARCOMA (UPS)

  Thursday, November 13, 2025
  1:30 PM - 3:00 PM EST

  Disclosure information not submitted.